|
Dear CCP4bb, Slightly off topic but perhaps of interest to students. Synopsis: The MARCO (MAchine Recognition of Crystallization Outcomes) project showed that automated image analysis can be used to classify experimental results,
having a 94% correct classification rate. Work on a custom image classifier using convolutional neural networks is already underway at AstraZeneca. In this project, the student will incorporate Active Learning into the training process to improve performance
and use additional information from UV images to achieve higher accuracy. As the main aim of the project, the student will then use the annotated crystallisation images to connect compounds or proteins with experimental conditions using novel graph-based networks. This is a 4-year iCASE studentship based in the Mathematics Department at the University of York fully funded by EPSRC and AstraZeneca. Link to details: Dr. David Hargreaves Associate Principal Scientist _____________________________________________________________________ AstraZeneca Discovery Sciences, Structure & Biophysics Dr David Hargreaves. Office R1-09/Lab FL54 AstraZeneca Darwin Building
Unit 310 Cambridge Science Park Milton Road Cambridge CB4 0WG telephone: +441223223546 mobile: 07525 742054 David.Hargreaves @astrazeneca.com Please consider the environment before printing this e-mail AstraZeneca UK Limited is a company incorporated in England and Wales with registered number:03674842 and its registered office at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA. This e-mail and its attachments are intended for the above named recipient only and may contain confidential and privileged information. If they have come to you in error, you must not copy or show them to anyone; instead, please reply to this e-mail, highlighting the error to the sender and then immediately delete the message. For information about how AstraZeneca UK Limited and its affiliates may process information, personal data and monitor communications, please see our privacy notice at www.astrazeneca.com To unsubscribe from the CCP4BB list, click the following link: |